The current valuation score of Adaptive Biotechnologies Corp is 6.95, ranking 236 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -70.34, which is -97.76% below the recent high of -1.57 and -7.13% above the recent low of -75.36.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.